Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a new revision of the study record in the site footer.
    Difference
    0.0%
    Check dated 2026-08-30T22:37:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a newer site version but does not imply changes to the study details presented on the page.
    Difference
    0.0%
    Check dated 2026-08-09T11:07:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small update to the page's documentation or template.
    Difference
    0.0%
    Check dated 2026-07-25T18:51:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.2 to v3.6.3, signaling a small update to the page rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-07-04T08:57:45.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a version update to the page content. This likely reflects minor edits or updates to the page's metadata or formatting.
    Difference
    0.0%
    Check dated 2026-06-27T04:37:58.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows updated recruitment messaging (No longer looking for participants). A heading label change from 'Intervention / Treatment' to 'Intervention/Treatment' and an updated site revision tag (Revision: v3.6.0) are also present.
    Difference
    0.4%
    Check dated 2026-06-13T00:28:38.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.